STOCK-BASED COMPENSATION (Tables)

12 Months Ended

May 31, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Recognized Stock-Based Compensation Expense

Stock-based compensation expense included in continuing operations was as follows:


	Fiscal Year Ended
(in millions)	May 31, 2026		May 25, 2025		May 26, 2024
Stock options	$	8.5	$	7.5	$	6.8
Restricted stock units	10.4		9.8		8.6
Darden stock units	30.2		37.3		31.9
Equity-settled performance-based restricted stock units	24.4		19.4		16.1
Employee stock purchase plan	3.5		3.2		3.0
Director compensation program/other	2.1		1.9		2.1
Total	$	79.1	$	79.1	$	68.5

Excess income tax benefits related to the exercise of stock options and vesting of other equity-settled stock-based compensation recognized in income tax expense from continuing operations was as follows:


	Fiscal Year Ended
(in millions)	May 31, 2026		May 25, 2025		May 26, 2024
Income tax benefits	$	9.5	$	11.8	$	12.7

Schedule of Weighted-Average Fair Value and Related Assumptions for Stock-Based Compensation

The weighted-average fair value of non-qualified stock options and the related assumptions used in the Black-Scholes model to record stock-based compensation are as follows:


	Granted in Fiscal Year Ended
	May 31, 2026			May 25, 2025			May 26, 2024
Weighted-average fair value	$	72.10		$	44.79		$	55.56
Dividend yield	2.9		%	3.6		%	3.4		%
Expected volatility of stock	41.3		%	40.8		%	42.2		%
Risk-free interest rate	4.0		%	4.1		%	4.0		%
Expected option life (in years)	6.3			6.3			5.9
Weighted-average exercise price per share	$	208.51		$	139.43		$	169.02

The weighted-average grant date fair value of equity-settled PRSUs and the related assumptions used in the Monte Carlo simulation to record stock-based compensation are as follows:


	Granted in Fiscal Year Ended
	May 31, 2026			May 25, 2025			May 26, 2024
Dividend yield (1)	0.0		%	0.0		%	0.0		%
Expected volatility of stock	25.8		%	26.5		%	32.3		%
Risk-free interest rate	3.7		%	4.2		%	4.5		%
Expected option life (in years)	3.8			2.9			2.9
Weighted-average grant date fair value per unit	$	244.14		$	181.65		$	217.11

(1)Assumes a reinvestment of dividends.

Schedule of Stock Option Activity

The following table presents a summary of our stock option activity as of and for the year ended May 31, 2026:


	Options (in millions)	Weighted-Average Exercise Price Per Share	Weighted-Average Remaining Contractual Life (Yrs)	Aggregate Intrinsic Value (in millions)
Outstanding beginning of period	1.03	$125.30	6.16	$80.9
Options granted	0.11	208.51
Options exercised	(0.12)	93.62
Options canceled	(0.01)	173.10
Outstanding end of period	1.01	$138.13	5.78	$67.2
Exercisable	0.60	$122.47	4.37	$49.1

Schedule of Restricted Stock and RSU Activity

The following table presents a summary of our restricted stock and RSU activity1 as of and for the fiscal year ended May 31, 2026:


	Shares (in millions)	Weighted-Average Grant Date Fair Value Per Share
Outstanding beginning of period	0.26	$135.67
Shares granted	0.06	208.14
Shares vested	(0.07)	133.13
Shares canceled	(0.01)	165.84
Outstanding end of period	0.24	$183.85

1 Includes RSUs issued under Director compensation program

Schedule of Darden Stock Unit Activity

The following table presents a summary of our Darden stock unit activity as of and for the fiscal year ended May 31, 2026:


(All units settled in cash)	Units (in millions)	Weighted-Average Fair Value Per Unit
Outstanding beginning of period	0.64	$204.02
Units granted	0.13	207.47
Units vested	(0.21)	203.09
Units canceled	(0.03)	160.08
Outstanding end of period	0.53	$203.91

Schedule of Performance Stock Unit Activity

The following table presents a summary of our equity-settled PRSU activity as of and for the fiscal year ended May 31, 2026:


	Units (in millions)	Weighted-Average Grant Date Fair Value Per Unit
Outstanding beginning of period	0.33	$175.95
Units granted	0.16	244.14
Units granted/canceled performance impact	0.10	137.73
Units vested	(0.15)	147.08
Units canceled	—	—
Outstanding end of period	0.44	$200.84